Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: A single centre experience [2]

Age and Ageing

Volumn 36, Issue 5, 2007, Pages 577-579

  Uyttenboogaart, Maarten ^a   Schrijvers, Elisabeth M C ^a   Vroomen, Patrick C ^a   De keyser, Jacques ^a   Luijckx, Gert Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; BLOOD ANALYSIS; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 35248865361     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afm022     Document Type: Letter

References (17)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-87.
2. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
3. Hacke W, Kaste M, Fieschi C et al. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-51.
4. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-26.
5. Di Carlo A, Lamassa M, Pracucci G et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke 1999; 30: 2313-19.
6. Tanne D, Gorman MJ, Bates VE et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : The tPA stroke survey experience. Stroke 2000; 31: 370-5.
7. Mouradian MS, Senthilselvan A, Jickling G et al. Intravenous rt-PA for acute stroke: Comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatr 2005; 76: 1234-7.
8. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on die very old: Experience from a single Dutch centre. J Neurol Neurosurg Psychiatr 2006; 77: 375-7.
9. Engelter ST, Reichhart M, Sekoranja L et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005; 65: 1795-8.
10. Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis for acute ischemic stroke patients aged 80 years and older: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatr 2006; 77: 826-9.
11. Chen CI, Iguchi Y, Grotta JC et al. Intravenous TPA for very old stroke patients. Eur Neurol 2005; 54: 140-4.
12. Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or = 80 years) stroke patients. Stroke 2005; 36: 2421-5.
13. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > = 80 versus <80 years of age-a systematic review across cohort studies. Age Ageing 2006; 35: 572-80.
14. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural-history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
15. Demaerschalk B, Merino JG, Silver B et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients > = 80 years old: The London, Canada experience. Abstracts of the International Stroke Conference. Stroke 2000; 32: 368-36d.
16. Simon JE, Sandler DL, Pexman JH, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience. Age Ageing 2004; 33: 143-9.
17. Kammersgaard LP, Jorgensen HS, Reith J, Nakayama H, Pedersen PM, Olsen TS, The Copenhagen Stroke Study. Short-and long-term prognosis for very old stroke patients. Age Ageing 2004; 33: 149-54.